Standout Papers

Primary prevention of cardiovascular disease with atorvastatin in type 2 d... 1998 2026 2007 2016 2.7k
  1. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial (2004)
    Helen M. Colhoun, D. J. Betteridge et al. The Lancet
  2. Vascular Risk Factors and Diabetic Neuropathy (2005)
    Solomon Tesfaye, Nish Chaturvedi et al. New England Journal of Medicine
  3. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes (1998)
    Nish Chaturvedi, Judith Stephenson et al. The Lancet

Immediate Impact

2 by Nobel laureates 102 standout
Sub-graph 1 of 13

Citing Papers

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
2020 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
62 intermediate papers

Works of John Fuller being referenced

High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
2006
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
and 17 more

Author Peers

Author Last Decade Papers Cites
John Fuller 4951 2679 3050 98 11.0k
Saul Genuth 7138 2106 2124 111 11.5k
H. A. W. Neil 9999 3154 6313 112 16.9k
David R. Hadden 7383 1153 3689 134 13.6k
Hans‐Henrik Parving 8066 7647 2099 122 17.2k
Jacqueline C.M. Witteman 1971 4073 1553 91 12.4k
Russell Scott 5727 1837 4665 237 11.1k
K. Borch‐Johnsen 5331 2922 1725 174 12.2k
D. J. Betteridge 4158 2281 3442 141 9.6k
Jacqueline C.M. Witteman 1333 5247 1334 108 11.6k
Y. Antero Kesäniemi 3612 2282 3639 184 9.7k

All Works

Loading papers...

Rankless by CCL
2026